Rhythm Pharmaceuticals (RYTM) Research & Development (2020 - 2025)
Historic Research & Development for Rhythm Pharmaceuticals (RYTM) over the last 6 years, with Q3 2025 value amounting to $46.0 million.
- Rhythm Pharmaceuticals' Research & Development rose 2134.4% to $46.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $166.5 million, marking a year-over-year decrease of 2655.97%. This contributed to the annual value of $238.0 million for FY2024, which is 7632.84% up from last year.
- Per Rhythm Pharmaceuticals' latest filing, its Research & Development stood at $46.0 million for Q3 2025, which was up 2134.4% from $42.3 million recorded in Q2 2025.
- In the past 5 years, Rhythm Pharmaceuticals' Research & Development registered a high of $128.7 million during Q1 2024, and its lowest value of $19.9 million during Q1 2021.
- In the last 5 years, Rhythm Pharmaceuticals' Research & Development had a median value of $32.5 million in 2022 and averaged $37.4 million.
- In the last 5 years, Rhythm Pharmaceuticals' Research & Development surged by 23908.29% in 2024 and then tumbled by 7126.41% in 2025.
- Over the past 5 years, Rhythm Pharmaceuticals' Research & Development (Quarter) stood at $31.6 million in 2021, then decreased by 25.42% to $23.5 million in 2022, then rose by 26.94% to $29.9 million in 2023, then skyrocketed by 37.72% to $41.2 million in 2024, then grew by 11.8% to $46.0 million in 2025.
- Its Research & Development stands at $46.0 million for Q3 2025, versus $42.3 million for Q2 2025 and $37.0 million for Q1 2025.